Skip to Main Content

KIRYAT SHMONA, Israel — As you drive toward the industrial park in this border town, you pass a disquieting sight: the abandoned skeleton of a thread factory that shuttered 18 years ago. Broken glass litters the concrete floor, and behind a door condemned with “NO PASSAGE” in red spray paint, huge canisters lean against one another like dead bodies.

It’s a foreboding omen of what could happen if the world’s largest generic drug manufacturer, Teva Pharmaceutical Industries, were to pull out of this northern Israeli city.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!